Concepedia

Yvonne Y. Yip

YY

7

Publications

273

Citations

7

H-Index

2003

Active since

Affiliations

Eli Lilly (United States)(Current)

Yvonne Y. Yip is an author at Eli Lilly (United States) specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

2003–2016

7

Publications

7

Characterization of LY3023414, a Novel PI3K/mTOR Dual Inhibitor Eliciting Transient Target Modulation to Impede Tumor Growth

Michèle C. Smith, Mary M. Mader, James A. Cook et al. · Molecular Cancer Therapeutics · 2016 · 74 citations

Discovery of a novel bicycloproline P2 bearing peptidyl α-ketoamide LY514962 as HCV protease inhibitor

Yvonne Y. Yip, Frantz Victor, Jason Lamar et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 65 citations · Full text

, , +9

P4 and P1′ optimization of bicycloproline P2 bearing tetrapeptidyl α-ketoamides as HCV protease inhibitors

Yvonne Y. Yip, Frantz Victor, Jason Lamar et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 41 citations · Full text

, , +9

P1 and P3 optimization of novel bicycloproline P2 bearing tetrapeptidyl α-ketoamide based HCV protease inhibitors

Frantz Victor, Jason Lamar, Nancy Snyder et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 32 citations · Full text

, , +11

P3 cap modified Phe*-Ala series BACE inhibitors

Shuhui Chen, Jason Lamar, Deqi Guo et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 25 citations · Full text

, , +6

Rows per page

1–5 of 7